Trade Rocket Pharmaceuticals Inc - RCKT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.37 |
| Open | 7.15 |
| 1-Year Change | -69.72% |
| Day's Range | 7.1 - 7.34 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 7.37 | 0.28 | 3.95% | 7.09 | 7.44 | 7.05 |
| Apr 23, 2025 | 7.07 | -0.08 | -1.12% | 7.15 | 7.38 | 6.95 |
| Apr 22, 2025 | 6.91 | -0.29 | -4.03% | 7.20 | 7.20 | 6.67 |
| Apr 21, 2025 | 7.11 | 0.96 | 15.61% | 6.15 | 7.38 | 6.15 |
| Apr 17, 2025 | 6.28 | 0.24 | 3.97% | 6.04 | 6.33 | 6.00 |
| Apr 16, 2025 | 6.10 | -0.15 | -2.40% | 6.25 | 6.25 | 5.85 |
| Apr 15, 2025 | 6.47 | 0.52 | 8.74% | 5.95 | 6.71 | 5.82 |
| Apr 14, 2025 | 5.86 | 0.51 | 9.53% | 5.35 | 5.99 | 5.16 |
| Apr 11, 2025 | 5.21 | 0.15 | 2.96% | 5.06 | 5.28 | 4.95 |
| Apr 10, 2025 | 4.87 | -0.27 | -5.25% | 5.14 | 5.20 | 4.79 |
| Apr 9, 2025 | 5.34 | 0.77 | 16.85% | 4.57 | 5.67 | 4.50 |
| Apr 8, 2025 | 4.72 | -0.59 | -11.11% | 5.31 | 5.41 | 4.72 |
| Apr 7, 2025 | 5.13 | 0.32 | 6.65% | 4.81 | 5.23 | 4.55 |
| Apr 4, 2025 | 5.05 | -0.27 | -5.08% | 5.32 | 5.37 | 5.05 |
| Apr 3, 2025 | 5.50 | -0.36 | -6.14% | 5.86 | 5.89 | 5.47 |
| Apr 2, 2025 | 6.24 | 0.57 | 10.05% | 5.67 | 6.25 | 5.65 |
| Apr 1, 2025 | 5.75 | -0.78 | -11.94% | 6.53 | 6.56 | 5.74 |
| Mar 31, 2025 | 6.59 | -0.56 | -7.83% | 7.15 | 7.16 | 6.20 |
| Mar 28, 2025 | 7.52 | -0.23 | -2.97% | 7.75 | 7.77 | 7.43 |
| Mar 27, 2025 | 7.82 | 0.18 | 2.36% | 7.64 | 7.92 | 7.59 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Rocket Pharma Company profile
About Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals, Inc. is a clinical-stage, multi-platform biotechnology company that is focused on the development of gene therapies for rare and devastating diseases. The Company’s clinical-stage ex vivo lentiviral vector (LVV) programs include: Fanconi Anemia (FA), is a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; Leukocyte Adhesion Deficiency-I (LAD-I), is a genetic disorder that causes the immune system to malfunction; Pyruvate Kinase Deficiency (PKD), is a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia, and Infantile Malignant Osteopetrosis (IMO), is a genetic disorder characterized by increased bone density and bone mass secondary to impaired bone resorption.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Rocket Pharmaceuticals Inc revenues was not reported. Net loss increased 21% to $169.1M. Higher net loss reflects research and development expense balanci increase of 15% to $113.5M (expense), General and administrative - Balancing increase of 47% to $24.5M (expense), Stock-based Compensation in SGA increase of 54% to $17.3M (expense).
| Industry: | Bio Therapeutic Drugs |
350 5th Ave Ste 7530
NEW YORK
NEW YORK 10118-7501
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com